awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37127542-91C04D3E-B33A-4DF8-8A56-F263870CAC0C
Q37127542-91C04D3E-B33A-4DF8-8A56-F263870CAC0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37127542-91C04D3E-B33A-4DF8-8A56-F263870CAC0C
Tailoring of chronic lymphatic leukemia therapy
P2860
Q37127542-91C04D3E-B33A-4DF8-8A56-F263870CAC0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37127542-91C04D3E-B33A-4DF8-8A56-F263870CAC0C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c6989298d7bf4f03bf48be77de5c1f342adecdd
P2860
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.